Dr. Ong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 W 10th Ave
Ground Floor
Columbus, OH 43210Phone+1 614-293-4448Fax+1 614-293-3277
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Neuro-Oncology, 2008 - 2010
SSM Health/Saint Louis University School of MedicineResidency, Neurology, 2005 - 2008- SSM Health/Saint Louis University School of MedicineInternship, Internal Medicine, 2004 - 2005
University of the East College of MedicineClass of 1995
Certifications & Licensure
OH State Medical License 2019 - 2026
AR State Medical License 2011 - 2020
IL State Medical License 2010 - 2011- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation
Clinical Trials
- Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
- Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects Start of enrollment: 2016 Oct 06
- LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma Start of enrollment: 2020 Oct 21
- Join now to see all
Publications & Presentations
PubMed
- 82 citationsOncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.Farshad Nassiri, Vikas Patil, Leeor S Yefet, Olivia Singh, Jeff Liu
Nature Medicine. 2023-06-01 - 7 citationsSmall Molecules and Immunotherapy Agents for Enhancing Radiotherapy in Glioblastoma.Jennifer K Matsui, Haley K Perlow, Alex R Ritter, Rituraj Upadhyay, Raju R Raval
Biomedicines. 2022-07-21 - 5 citationsTargeted Therapy for BRAF Mutant Brain TumorsAppaji Rayi, Iyad Alnahhas, Shirley Ong, Pierre Giglio, Vinay K. Puduvalli
Current Treatment Options in Oncology. 2021-10-06
Journal Articles
- Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.Nassiri F, Patil V, Yefet LS, Singh O, Liu J, Dang RMA, Yamaguchi TN, Daras M, Cloughesy TF, Colman H, Kumthekar PU, Chen CC, Aiken R, Groves MD, Ong SS, Ramakrishna R..., Nature Medicine, 6/29/2023
Books/Book Chapters
Press Mentions
All Slots for Prestigious Neuro-Oncology Fellowship Filled by UAMS ResidentsJune 13th, 2017
Professional Memberships
- Member
- Member
- Society for Neuro-oncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
